Z160: Phase IIa started
Zalicus began a double-blind, placebo-controlled, U.S. Phase IIa trial to evaluate twice-daily 375 mg Z160 for 6 weeks in up to
Gathering data...
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
Gathering data...
Zalicus began a double-blind, placebo-controlled, U.S. Phase IIa trial to evaluate twice-daily 375 mg Z160 for 6 weeks in up to